Chronic heart failure: prevention and treatment options

The problem of chronic heart failure remains relevant today. According to the Age of CHF study, the prevalence of this disease in this country is 12%. In 66% of cases CHF has ischemic etiology. Rational approach to treatment and evaluation of all possible risks significantly improves patient's...

Full description

Bibliographic Details
Main Author: S. B. Migutina
Format: Article
Language:Russian
Published: Remedium Group LLC 2013-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/842
id doaj-1cfdfdff4da5403eaaee6048e9885fa6
record_format Article
spelling doaj-1cfdfdff4da5403eaaee6048e9885fa62021-07-28T13:29:12ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902013-12-0101-2566310.21518/2079-701X-2013-1-2-56-63842Chronic heart failure: prevention and treatment optionsS. B. Migutina0State Clinical Hospital No. 60, MoscowThe problem of chronic heart failure remains relevant today. According to the Age of CHF study, the prevalence of this disease in this country is 12%. In 66% of cases CHF has ischemic etiology. Rational approach to treatment and evaluation of all possible risks significantly improves patient's condition and reduces severity of the disease. Non-drug treatments include low-salt diet and physical rehabilitation based on balanced aerobic activity.Despite a huge list of drugs recommended and used at CHF, attention to medicines called myocardial cytoprotectors remains high.https://www.med-sovet.pro/jour/article/view/842хроническая сердечная недостаточностьпрофилактикалечениемиокардиальные цитопротекторыheart failurepreventiontreatmentmyocardial cytoprotectors
collection DOAJ
language Russian
format Article
sources DOAJ
author S. B. Migutina
spellingShingle S. B. Migutina
Chronic heart failure: prevention and treatment options
Медицинский совет
хроническая сердечная недостаточность
профилактика
лечение
миокардиальные цитопротекторы
heart failure
prevention
treatment
myocardial cytoprotectors
author_facet S. B. Migutina
author_sort S. B. Migutina
title Chronic heart failure: prevention and treatment options
title_short Chronic heart failure: prevention and treatment options
title_full Chronic heart failure: prevention and treatment options
title_fullStr Chronic heart failure: prevention and treatment options
title_full_unstemmed Chronic heart failure: prevention and treatment options
title_sort chronic heart failure: prevention and treatment options
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2013-12-01
description The problem of chronic heart failure remains relevant today. According to the Age of CHF study, the prevalence of this disease in this country is 12%. In 66% of cases CHF has ischemic etiology. Rational approach to treatment and evaluation of all possible risks significantly improves patient's condition and reduces severity of the disease. Non-drug treatments include low-salt diet and physical rehabilitation based on balanced aerobic activity.Despite a huge list of drugs recommended and used at CHF, attention to medicines called myocardial cytoprotectors remains high.
topic хроническая сердечная недостаточность
профилактика
лечение
миокардиальные цитопротекторы
heart failure
prevention
treatment
myocardial cytoprotectors
url https://www.med-sovet.pro/jour/article/view/842
work_keys_str_mv AT sbmigutina chronicheartfailurepreventionandtreatmentoptions
_version_ 1721274795938545664